Syndax Pharmaceuticals In... (SNDX)
NASDAQ: SNDX
· Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
15.97
1.69%
After-hours: Aug 15, 2025, 06:30 PM EDT
Syndax Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 108.64M | 153.99M | 154.08M | 133.02M | 105.4M | 114.61M | 295.39M | 94.55M | 97.28M | 57.52M | 74.36M | 71.38M | 120.24M | 188.77M | 221.97M | 71.43M | 68.04M | 64.39M |
Short-Term Investments | 360.07M | 358.2M | 428.83M | 256.59M | 319.7M | 319.96M | 282.19M | 279.27M | 308.75M | 380.69M | 410.04M | 279.33M | 256.44M | 222.14M | 217.97M | 158.28M | 185.09M | 206.95M |
Long-Term Investments | 62.63M | 89.94M | 119.52M | 10.03M | 29.73M | 87.63M | 29.83M | 15.71M | 19.48M | 16.56M | 5.47M | n/a | 12.13M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 217K | 217K | 217K | 217K | 156K | 248K | 680K | 804K | 796K | 808K | 9.44M | 881K | 995K | 1.03M | n/a | n/a | n/a | 115K |
Receivables | 37.42M | 15.72M | 13.87M | 4.69M | 10.88M | 7.59M | 1.23M | 4.2M | 534K | 2.07M | 4.06M | 4.95M | 13.51M | 158K | 429K | 182K | 433K | 279K |
Inventory | 17.7M | 4.66M | 366K | n/a | n/a | n/a | 2M | 2.68M | 2.24M | -9.69M | -4.25M | 1.82M | 1.91M | 2.27M | 7.65M | 8.12M | 8.82M | 7.21M |
Other Current Assets | 1.47M | 16.17M | 612K | 17.01M | 7.23M | 8.67M | 63K | 277K | 279K | 5.98M | 8.79M | 267K | 298K | 6.83M | 7.27M | 356K | 288K | 4.97M |
Total Current Assets | 531.68M | 548.75M | 603.06M | 414.81M | 446.06M | 453.9M | 580.88M | 380.97M | 409.08M | 441.51M | 481.27M | 357.63M | 392.29M | 420.06M | 448.4M | 238.25M | 262.56M | 278.95M |
Property-Plant & Equipment | 1.63M | 1.8M | 2.02M | 756K | 1M | 1.25M | 1.5M | 1.74M | 1.98M | 946K | 1.06M | 1.18M | 1.03M | 1.14M | 1.26M | 1.25M | 504K | 610K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 64.47M | 91.96M | 121.76M | 11M | 30.89M | 89.13M | 32M | 18.25M | 22.26M | 18.32M | 15.96M | 2.06M | 14.15M | 2.17M | 1.26M | 1.25M | 504K | 725K |
Total Assets | 596.15M | 640.71M | 724.82M | 425.81M | 476.95M | 543.03M | 612.88M | 399.22M | 431.34M | 459.83M | 497.24M | 359.69M | 406.44M | 422.22M | 449.66M | 239.5M | 263.06M | 279.67M |
Account Payables | 17.35M | 10.05M | 11.63M | 4.9M | 11.57M | 8.81M | 9.96M | 6.05M | 10.98M | 8.06M | 4.35M | 7.12M | 6.44M | 8.23M | 5.67M | 5.12M | 3.62M | 6.53M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 38.97M | 31.35M | 17.69M | n/a | n/a | n/a | 13.81M | n/a | 12.76M | 13.54M | 1.52M | 1.52M |
Short-Term Debt | n/a | n/a | 12.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.21M | 3.57M | n/a | 9.49M | 7.03M | 4.63M |
Other Current Liabilities | 39.76M | 84.5M | 15.75M | 42.02M | 22.13M | 36.38M | 8.12M | 768K | 1.03M | 12.15M | 18.33M | 9.21M | 3.17M | 16.48M | 1.89M | 188K | 9.19M | 9.84M |
Total Current Liabilities | 112.99M | 94.55M | 103.55M | 59.38M | 42.47M | 50.8M | 58.1M | 39.17M | 30.17M | 23.72M | 29.07M | 20.8M | 30.93M | 30.55M | 20.68M | 28.71M | 24.29M | 24.57M |
Long-Term Debt | n/a | n/a | 331.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.99M | 16.48M | 19.89M | 10.99M | 13.32M | 15.6M |
Other Long-Term Liabilities | 324.41M | 236.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 325.74M | 236.55M | 333.14M | 2K | 137K | 334K | 588K | 864K | 1.13M | 600K | 722K | 782K | 13.57M | 17.12M | 20.61M | 11.79M | 24.2M | 26.9M |
Total Liabilities | 438.73M | 425.65M | 436.69M | 59.38M | 42.61M | 51.14M | 58.68M | 40.04M | 31.3M | 24.32M | 29.79M | 21.59M | 44.5M | 47.67M | 41.29M | 40.5M | 48.5M | 51.47M |
Total Debt | 1.68M | 345.63M | 345.74M | 854K | 1.13M | 1.39M | 1.64M | 1.87M | 2.1M | 1.06M | 1.16M | 1.26M | 21.09M | 21.02M | 20.97M | 21.64M | 20.77M | 20.77M |
Common Stock | 9K | 9K | 9K | 9K | 9K | 8K | 8K | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 6K | 5K | 5K | 5K |
Retained Earnings | -1.38B | -1.31B | -1.22B | -1.13B | -1.04B | -974.8M | -902.4M | -829.93M | -778.78M | -734.17M | -693.04M | -653.85M | -618.44M | -580.87M | -543.7M | -639.9M | -619.26M | -596.35M |
Comprehensive Income | 285K | n/a | 163K | 371K | -817K | -756K | 218K | -455K | -574K | -336K | -806K | -1.6M | -1.33M | -640K | 45K | 11K | 17K | 9K |
Shareholders Equity | 157.42M | 215.06M | 288.12M | 366.43M | 434.34M | 491.89M | 554.2M | 359.19M | 400.04M | 435.5M | 467.45M | 338.1M | 361.94M | 374.55M | 408.37M | 199M | 214.56M | 228.21M |
Total Investments | 422.7M | 448.14M | 548.35M | 266.62M | 349.43M | 407.6M | 305.13M | 284.71M | 321.01M | 391.44M | 406.92M | 279.33M | 268.56M | 222.14M | 217.97M | 158.28M | 185.09M | 206.95M |